Does THIOTEPA Cause Acute graft versus host disease? 331 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 331 reports of Acute graft versus host disease have been filed in association with THIOTEPA (Thiotepa). This represents 4.8% of all adverse event reports for THIOTEPA.
331
Reports of Acute graft versus host disease with THIOTEPA
4.8%
of all THIOTEPA reports
98
Deaths
36
Hospitalizations
How Dangerous Is Acute graft versus host disease From THIOTEPA?
Of the 331 reports, 98 (29.6%) resulted in death, 36 (10.9%) required hospitalization, and 19 (5.7%) were considered life-threatening.
Is Acute graft versus host disease Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for THIOTEPA. However, 331 reports have been filed with the FAERS database.
What Other Side Effects Does THIOTEPA Cause?
Off label use (762)
Febrile neutropenia (645)
Mucosal inflammation (616)
Cytomegalovirus infection (446)
Product use in unapproved indication (425)
Pyrexia (359)
Drug ineffective (358)
Acute graft versus host disease in skin (355)
Cytomegalovirus infection reactivation (325)
Infection (318)
What Other Drugs Cause Acute graft versus host disease?
CYCLOSPORINE (1,043)
MYCOPHENOLATE MOFETIL (1,021)
FLUDARABINE (715)
CYCLOPHOSPHAMIDE (710)
TACROLIMUS (686)
METHOTREXATE (656)
BUSULFAN (337)
LAPINE T-LYMPHOCYTE IMMUNE GLOBULIN (245)
RUXOLITINIB (240)
MELPHALAN (224)
Which THIOTEPA Alternatives Have Lower Acute graft versus host disease Risk?
THIOTEPA vs THIOTHIXENE
THIOTEPA vs THROMBIN
THIOTEPA vs THROMBIN HUMAN
THIOTEPA vs THYMOCYTE IMMUNE GLOBULIN NOS
THIOTEPA vs THYMOGLOBULINE